Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$191.17 - $325.63 $289,049 - $492,352
1,512 Added 33.29%
6,054 $1.97 Million
Q4 2023

Jan 31, 2024

BUY
$160.99 - $215.69 $7,244 - $9,706
45 Added 1.0%
4,542 $865,000
Q3 2023

Oct 23, 2023

BUY
$194.33 - $283.97 $59,464 - $86,894
306 Added 7.3%
4,497 $895,000
Q2 2023

Aug 07, 2023

BUY
$223.05 - $302.68 $353,311 - $479,445
1,584 Added 60.76%
4,191 $1.2 Million
Q1 2023

May 04, 2023

BUY
$175.41 - $217.92 $28,416 - $35,303
162 Added 6.63%
2,607 $565,000
Q4 2022

Feb 06, 2023

BUY
$204.38 - $296.82 $499,709 - $725,724
2,445 New
2,445 $502,000
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $3,199 - $5,184
-25 Closed
0 $0
Q4 2021

Feb 02, 2022

BUY
$165.13 - $241.83 $4,128 - $6,045
25 New
25 $4,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Robbins Farley LLC Portfolio

Follow Robbins Farley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robbins Farley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robbins Farley LLC with notifications on news.